We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+6.95%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$294B
AUM Growth
+$23.6B
Cap. Flow
+$7.38B
Cap. Flow %
2.51%
Top 10 Hldgs %
16.68%
Holding
4,142
New
98
Increased
2,556
Reduced
827
Closed
120

Sector Composition

Rank Sector Weight
1 Technology 16.85%
2 Financials 16.38%
3 Healthcare 13.22%
4 Industrials 10.47%
5 Consumer Discretionary 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNDM icon
3901
Tandem Diabetes Care
TNDM
$1.26B
$40K ﹤0.01%
16,996
-1,060
-6% -$3.33K
HTGM
3902
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$40K ﹤0.01%
110
TGA
3903
DELISTED
Transglobe Energy Corp
TGA
$40K ﹤0.01%
26,813
-4,386
-14% -$6.5K
PZG icon
3904
Paramount Gold Nevada
PZG
$93.5M
$39K ﹤0.01%
30,702
RSLS
3905
DELISTED
ReShape Lifesciences Inc. Common Stock
RSLS
$39K ﹤0.01%
+13
New +$43K
MBOT icon
3906
Microbot Medical
MBOT
$114M
$38K ﹤0.01%
2,549
-783
-23% -$13.3K
FCSC
3907
DELISTED
Fibrocell Science Inc.
FCSC
$38K ﹤0.01%
11,742
STLY
3908
DELISTED
Stanley Furniture Co Inc
STLY
$38K ﹤0.01%
44,313
ARMP icon
3909
Armata Pharmaceuticals
ARMP
$176M
$37K ﹤0.01%
2,675
BGMS
3910
Bio Green Med Solution Inc
BGMS
$4.86M
0
HPJ
3911
DELISTED
Highpower International Inc
HPJ
$37K ﹤0.01%
10,264
TENX icon
3912
Tenax Therapeutics
TENX
$403M
$36K ﹤0.01%
2
-1
-33% -$13.6K
WORX
3913
DELISTED
SCWORX CORP NEW
WORX
$36K ﹤0.01%
+7
New +$46.7K
CVO
3914
DELISTED
Cenevo, Inc.
CVO
$36K ﹤0.01%
40,373
TMBR
3915
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$35K ﹤0.01%
22
ASTC icon
3916
Astrotech Corp
ASTC
$12.4M
$34K ﹤0.01%
345
-346
-50% -$36.2K
TULP
3917
Bloomia Holdings
TULP
$16.1M
$34K ﹤0.01%
4,096
FAC
3918
DELISTED
First Acceptance Corp.
FAC
$34K ﹤0.01%
28,734
VTGN icon
3919
VistaGen Therapeutics
VTGN
$10.3M
$33K ﹤0.01%
1,003
AMTX icon
3920
Aemetis
AMTX
$102M
$32K ﹤0.01%
59,740
TANH icon
3921
Tantech Holdings
TANH
$6.02M
$31K ﹤0.01%
1
SCON
3922
DELISTED
Superconductor Technologies Inc.
SCON
$31K ﹤0.01%
288
SSY
3923
DELISTED
SunLink Health Systems
SSY
$30K ﹤0.01%
19,190
SCPX
3924
DELISTED
Scorpius Holdings, Inc.
SCPX
0
OTIV
3925
DELISTED
OTI On Track Innovations Ltd
OTIV
$30K ﹤0.01%
22,179

Similar funds

Geode Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Geode Capital Management held 4,142 positions worth $294B, up 8.7% from $271B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Geode Capital Management's Q4 2017 filing shows 98 new, 2,556 increased, 827 reduced and 120 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 742,921 shares worth $39M. The largest sale was CR Bard Inc., an estimated $243M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 742,921 shares worth $39M.
  • Geode Capital Management added most to Apple in Q4 2017, an estimated $227M increase.
  • Geode Capital Management's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $23.7M.
  • Geode Capital Management fully exited CR Bard Inc. in Q4 2017, selling an estimated $243M.
  • Geode Capital Management's ten largest holdings make up 17% of its $294B portfolio in Q4 2017.
  • Geode Capital Management opened 98 new positions and closed 120 in Q4 2017.
  • Geode Capital Management's portfolio value rose 8.7% quarter-over-quarter to $294B.

Based on Geode Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.